Aurora Cannabis Appoints Kerry Miller to Boost Leadership in Australia and New Zealand

Aurora Cannabis Strengthens Leadership in Australia and New Zealand with New Appointment

Aurora Cannabis Inc., a prominent player in the global medical cannabis market, announces the appointment of Kerry Miller as the new Managing Director for Australia and New Zealand, effective January 15, 2026. This strategic move underscores Aurora's commitment to expanding its presence in these key markets. Miller brings a wealth of experience from his 35-year career in the consumer packaged goods sector, most notably his 25-year tenure at Reckitt Benckiser and nearly a decade at Unilever. His proven track record in leading global transformation initiatives is anticipated to drive substantial growth for Aurora in Australia and New Zealand, regions that are increasingly recognizing the therapeutic benefits of cannabis.

Miller's extensive background in managing global teams and transforming market strategies aligns well with Aurora's mission to enhance access to medical cannabis products. As the company continues to innovate and refine its offerings, his expertise will be pivotal in navigating the complexities of these evolving markets. Aurora currently provides a diverse range of medical and consumer cannabis products under respected brands such as Drift, San Rafael '71, and MedReleaf, positioning itself as a leader in the industry. The appointment of Miller reinforces the company’s strategic emphasis on leadership that can adapt to the dynamic landscape of cannabis regulation and consumer acceptance.

In light of the growing acceptance of medical cannabis, Aurora aims to leverage Miller's experience to enhance its market share and drive topline growth. The company is dedicated to delivering high-quality products while maintaining a focus on innovation and patient access. As Aurora solidifies its footing in Australia and New Zealand, the leadership transition is expected to catalyze further expansion and reinforce the company's reputation as a pioneering force in the cannabis sector.

In addition to its medical cannabis offerings, Aurora holds a significant stake in Bevo Farms Ltd., a leading supplier of propagated agricultural plants, which contributes to its diverse portfolio. By fostering strong leadership and a commitment to quality, Aurora Cannabis continues to navigate the complexities of the global cannabis market while focusing on delivering value to its patients and stakeholders. With its shares traded on the NASDAQ and TSX, the company remains at the forefront of the cannabis revolution.